Scientists hunt for harmful immune cells in MS patients

NCT ID NCT04798651

Recruiting now Knowledge-focused Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at blood and spinal fluid from 150 people with multiple sclerosis or early symptoms. Researchers want to find which types of B and T cells cause damage in different forms of MS. The goal is to discover new targets for future treatments, especially for progressive MS.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could point toward new treatment targets for multiple sclerosis, especially for progressive forms.
What could go wrong: This is an observational study, not a treatment trial. It may not directly lead to new therapies, and results may take years to translate into clinical use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLINICALLY ISOLATED SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autoimmune disorder of the nervous system multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CLINICALLY ISOLATED SYNDROME MULTIPLE SCLEROSIS

Contacts and locations

Locations

CHU de Bordeaux - service de neurologie
RECRUITING

Bordeaux, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.